Glucose Biosensors Market Report 2025 – Strategic Data for Growth and Expansion

 We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

 
 What is the anticipated market size of the glucose biosensors industry over the next few years?
 The glucose biosensors market size has grown rapidly in recent years. It will grow from$15.26 billion in 2024 to $16.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to research and development, cost-efficiency, user-friendly design, increasing diabetes prevalence, integration with smart devices, non-invasive monitoring techniques
 
 The glucose biosensors market size is expected to see rapid growth in the next few years. It will grow to “$27.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to personalized healthcare solutions, rise in diabetes cases, continuous glucose monitoring expansion, integration with wearable tech, non-invasive monitoring development. Major trends in the forecast period include eco-friendly biosensor designs, interconnectivity and data sharing, home healthcare empowerment, non-invasive monitoring techniques, implantable biosensors.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=10708&type=smp
 
 What emerging drivers are expected to shape the future of the glucose biosensors market?
 The rising prevalence of diabetes is expected to propel the growth of the glucose biosensors market going forward. Diabetes is an incurable disease that arises when the pancreas fails to create enough insulin or when the body fails to adequately utilize the insulin that is produced. Diabetes patients utilize glucose biosensors to monitor their blood glucose levels which enables them to monitor their blood glucose levels regularly at their convenience and helps to adjust their medication for better diabetes management. For instance, in June 2024, according to the NHS England, a UK-based governing body, in 2023, 3,615,330 individuals registered with a GP were identified as having non-diabetic hyperglycemia, commonly referred to as pre-diabetes, marking an increase from 3,065,825 in 2022 an increase of nearly 18%. Therefore, the rising prevalence of diabetes is driving the growth of the glucose biosensors market.
 
 What emerging segments are shaping the future landscape of the glucose biosensors industry?
 The glucose biosensors market covered in this report is segmented –
 
 1) By Product Type: Continuous Glucose Monitoring, Self-monitoring Blood Glucose, Non-invasive Glucose Monitoring
 2) By Technology: Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Others Technologies
 3) By End Users: Hospitals, Home Care, Diagnostic Centers and Clinics, Other End Users
 
 Subsegments:
 1) By Continuous Glucose Monitoring (CGM): Real-time CGM systems, Professional CGM systems, Integration with insulin pumps, Sensor types
 2) By Self-monitoring Blood Glucose (SMBG): Glucometers, Test strips, Blood sample types
 3) By Non-invasive Glucose Monitoring: Optical glucose sensors, Transdermal sensors, Wearable devices
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report
 
 What are the key trends shaping the glucose biosensors market in the forecast period?
 Major companies operating in the glucose biosensor market are focusing on innovative product launches, such as the glucose monitoring systems, to help individuals with diabetes. Glucose monitoring systems are devices designed to continuously measure and deliver real-time blood glucose level data, aiding individuals in effectively managing diabetes. For instance, in October 2024, DexCom Inc. US-based biotechnology company introduced the Stelo Glucose Biosensor System, which is the first over-the-counter (OTC) continuous glucose monitor (CGM) approved by the U.S. Food and Drug Administration (FDA). The Stelo system is designed for adults aged 18 and older who do not use insulin, including those with Type 2 diabetes or prediabetes. It can also be used by individuals without diabetes who wish to monitor their glucose levels to understand how diet and exercise affect their blood sugar.
 
 How are key players in the glucose biosensors market strengthening their market position?
 Major companies operating in the glucose biosensors market include Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, GlySens Incorporated, Trividia Health, Bayer AG, LifeScan Inc., Medtronic plc, Nova Biomedical Corporation, Senseonics Holdings, ACON Laboratories Inc., AgaMatrix Inc., Ypsomed AG, Ascencia Diabetes Care Holdings Inc., Bio-Rad Laboratories Inc., DuPont de Nemours Inc., Biosensors International Group Ltd., Cytiva, Universal Biosensors Inc., CARDEA BIO INC., Conductive Technologies Inc., EarlySense Inc., Innovative Sensor Technology IST AG, LifeSignals Inc., NeuroSky Inc., SD Biosensor INC., Xsensio, Taidoc Technology Corporation
 
 Which geographic areas are contributing significantly to the growth of the glucose biosensors sector?
 North America was the largest region in the glucose biosensors market in 2024. The regions covered in the glucose biosensors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 How Can Companies Use The Glucose Biosensors Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10708
 
 Need Customized Data On Glucose Biosensors Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=10708&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company